Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03030924 · ClinicalTrials.gov registry record

Wearable Suicidal Early Warning System for Adolescents

A clinical trial of Suicide and Adolescent Behavior, sponsored by Oregon Health and Science University.

Active
Registry status
250
Enrollment target
1
Study location

NCT03030924 is a study of Suicide and Adolescent Behavior that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 250 participants, below the 6,987-participant average among 92 other Suicide trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03030924, a study of Suicide and Adolescent Behavior, is active but no longer recruiting, sponsored by Oregon Health and Science University.

ACTIVE NOT RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department and an inpatient psychiatric adolescent unit with acute suicidality.

Interventions

  • DEVICE Solace

Study Locations (1)

Oregon

  • OHSU - Portland

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2017-09-18
Est. Completion 2026-06-01

What the Registry Record Tells You About NCT03030924

The ClinicalTrials.gov registry entry for NCT03030924 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,987-participant average among 92 other Suicide trials with a reported enrollment target (96% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Solace is the first listed.

NCT03030924 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT03030924 about?

NCT03030924 is a clinical study titled "Wearable Suicidal Early Warning System for Adolescents". This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department and an inpatient psychiatric adolescent unit with acute suicidality.

What is the current status of trial NCT03030924?

This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2017-09-18. Estimated completion is 2026-06-01.

What conditions does trial NCT03030924 study?

This clinical trial studies the following conditions: Suicide, Adolescent Behavior.

What interventions are being tested in trial NCT03030924?

The interventions under investigation include: Solace (DEVICE).

Who is sponsoring clinical trial NCT03030924?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03030924 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.